PFIZER INC Proceeds from (Repayments of) Short-term Debt
PFIZER INC (PFE) reported Proceeds from (Repayments of) Short-term Debt of $3.72 billion for the 9-month period ending 2013-09-29, per its 10-Q filed 2013-11-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfShortTermDebt · last filed 2013-11-08
- PFIZER INC proceeds from (repayments of) short-term debt for the quarter ending 2013-09-29 was $1.39B, a 28.25% decline year-over-year.
- PFIZER INC proceeds from (repayments of) short-term debt for the quarter ending 2013-06-30 was $2.33B, a 5.95% increase year-over-year.
- PFIZER INC proceeds from (repayments of) short-term debt for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- PFIZER INC proceeds from (repayments of) short-term debt for the quarter ending 2012-12-31 was $2.29B, a 28.21% decline year-over-year.
- PFIZER INC proceeds from (repayments of) short-term debt for fiscal 2012 was $8.00B, a 37.59% decline from fiscal 2011.
- PFIZER INC proceeds from (repayments of) short-term debt for fiscal 2011 was $12.81B, a 100.16% increase from fiscal 2010.
- PFIZER INC proceeds from (repayments of) short-term debt for fiscal 2010 was $6.40B, a 79.46% decline from fiscal 2009.
- PFIZER INC proceeds from (repayments of) short-term debt for fiscal 2009 was $31.16B.
| Period end | Proceeds from (Repayments of) Short-term Debt 3 month | Proceeds from (Repayments of) Short-term Debt 6 month | Proceeds from (Repayments of) Short-term Debt 9 month | Proceeds from (Repayments of) Short-term Debt 12 month |
|---|---|---|---|---|
| 2013-09-29 | $1.39B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $3.72B derived: sum of 2 quarters · filed 2013-11-08 | $3.72B 10-Q · filed 2013-11-08 | $6.02B derived: sum of 4 quarters · filed 2013-11-08 |
| 2013-06-30 | $2.33B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $2.33B 10-Q · filed 2013-08-09 | $4.63B derived: sum of 3 quarters · filed 2013-08-09 | $6.57B derived: sum of 4 quarters · filed 2013-11-08 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-10 | $2.29B derived: sum of 2 quarters · filed 2013-05-10 | $4.23B derived: sum of 3 quarters · filed 2013-11-08 | $6.43B derived: sum of 4 quarters · filed 2013-11-08 |
| 2012-12-31 | $2.29B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $4.23B derived: sum of 2 quarters · filed 2013-11-08 | $6.43B derived: sum of 3 quarters · filed 2013-11-08 | $8.00B 10-K · filed 2013-02-28 |
| 2012-09-30 | $1.94B derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $4.14B derived: sum of 2 quarters · filed 2013-11-08 | $5.70B 10-Q · filed 2013-11-08 | $8.90B derived: sum of 4 quarters · filed 2013-11-08 |
| 2012-07-01 | $2.20B derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $3.76B 10-Q · filed 2013-08-09 | $6.96B derived: sum of 3 quarters · filed 2013-08-09 | $11.71B derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-04-01 | $1.56B 10-Q · filed 2013-05-10 | $4.76B derived: sum of 2 quarters · filed 2013-05-10 | $9.50B derived: sum of 3 quarters · filed 2013-05-10 | $11.69B derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $3.20B derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $7.94B derived: sum of 2 quarters · filed 2013-02-28 | $10.13B derived: sum of 3 quarters · filed 2013-02-28 | $12.81B 10-K · filed 2013-02-28 |
| 2011-10-02 | $4.75B derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $6.93B derived: sum of 2 quarters · filed 2012-11-09 | $9.61B 10-Q · filed 2012-11-09 | |
| 2011-07-03 | $2.19B derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $4.87B 10-Q · filed 2012-08-09 | ||
| 2011-04-03 | $2.68B 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | $6.40B 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $31.16B 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |